Healthcare - Biotechnology - NASDAQ - DK
$ 1.44
-14.3 %
$ 8.16 M
Market Cap
-0.51
P/E
INCOME STATEMENT
73.1 K
REVENUE
-22.2 M
OPERATING INCOME
-22.1 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Evaxion Biotech A/S
| Revenue | 73.1 K |
| Cost Of Revenue | 0 |
| Gross Profit | 73.1 K |
| Operating Expenses | 22.3 M |
| Operating Income | -22.2 M |
| Other Expenses | -72 K |
| Net Income | -22.1 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 73.1 K | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0 | 0.6 | 0.3 | 0.1 | 81 K | 73.9 K |
| Gross Profit | 73.1 K | (0.6) | (0.3) | (0.1) | 81 K | 73.9 K |
| OPERATING INCOME | ||||||
| Operating Expenses | 22.3 | 25.3 | 25.8 | 16.6 | 10.9 | 5.6 |
| Selling, General and Administrative Expenses | 10.4 | 8.2 | 6.3 | 5.7 | 2.6 | 1.9 |
| Research and Development Expenses | 11.9 | 17.1 | 19.6 | 10.9 | 8.2 | 3.7 |
| Operating Income | (22.2) | (25.3) | (25.8) | (16.6) | (10.9) | (5.6) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0.9 | 1.5 | 0.9 | 0.2 | 1.2 | 0.7 |
| Total Other Income | (0.7) | 1.3 | 1.1 | 7 K | (1.2) | (0.6) |
| Pre-Tax Income | (22.9) | (23.9) | (24.7) | (16.6) | (12.0) | (6.3) |
| NET INCOME | ||||||
| Tax Provision | (0.8) | (0.8) | (0.2) | (1.6) | (0.8) | (0.7) |
| Net Income | (22.1) | (23.2) | (24.5) | (15.0) | (11.2) | (5.5) |
| EPS | 8.11 | 9.8 | 12.6 | 9.27 | 6.91 | 2.88 |